Gilead has just paid US$ 4.3B for an as yet to be proven drug as an additive therapy to its liver disease portfolio. ;
That amount for BIT would be $A7 for each share and option.
100x at price today and the market is comparatively massive for BIT225 plus potential from the library.
Gilead has just paid US$ 4.3B for an as yet to be proven drug as...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.002(3.51%) |
Mkt cap ! $49.62M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.8¢ | 5.5¢ | $48.93K | 874.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 40549 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 126191 | 3 |
View Market Depth
| Last trade - 15.32pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.5¢ |
Change
-0.002 ( 3.51 %) |
||||
| Open | High | Low | Volume | ||
| 5.8¢ | 5.8¢ | 5.5¢ | 262949 | ||
| Last updated 15.32pm 17/05/2024 ? | |||||
| BIT (ASX) Chart |